Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0002-2038-5863Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Jimin Min, Lisa Schweizer, Gijs Zonderland…·Anirban Maitra
This study uses AI-driven proteomics to identify molecular transitions in pancreatic cancer precursors, revealing early molecular changes in histologically normal tissue.
Zeynep Dereli, Behnaz Bozorgui, Maga Sanchez…·Anil Korkut
This study creates a spatial proteomic atlas of SBA tumor-immune microenvironment, revealing cell interactions and immune checkpoint patterns linked to patient survival and therapy.
Debora Barbosa Vendramini Costa, Ralph Francescone, Janusz Franco‐Barraza…·Edna Cukierman
This paper identifies NGL-1 as a stromal immunomodulator in pancreatic cancer that promotes tumor growth by modulating the tumor microenvironment through TGF-β and transcription factor pathways.